Konruns(603590) 证券之星·2025-03-31 08:21Core Points - Beijing Kangchen Pharmaceutical Co., Ltd. has completed the industrial and commercial change registration and obtained a new business license [1][2] - The company held a board meeting on October 29, 2024, to discuss amendments to certain provisions of its articles of association [1] - The updated business registration information includes a registered capital of 1,593.56477 million yuan and a legal representative named Liu Jianhua [1] Company Information - The company is classified as a joint-stock company (listed, natural person investment or control) [1] - The registered address is located at No. 11, Xingsheng South Road, Economic Development Zone, Miyun District, Beijing [1] - The business scope includes the production of lyophilized powder injections, biochemical raw materials, tablets (including anti-tumor drugs), biopharmaceutical development and research, technology promotion services, and technology transfer and consulting services (excluding intermediary services) [1][2]